Overview

Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The current study has been designed to address the significance of early onset of response prospectively in patients treated with an atypical antipsychotic.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Antipsychotic Agents
Olanzapine
Risperidone